Thurston, Springer, Miller, Herd & Titak, Inc. Assertio Holdings, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $283 Million
- Q2 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 12,500 shares of ASRT stock, worth $15,750. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,500
Previous 44,144
71.68%
Holding current value
$15,750
Previous $42,000
64.29%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ASRT
# of Institutions
114Shares Held
37.2MCall Options Held
755KPut Options Held
39.5K-
Nantahala Capital Management, LLC New Canaan, CT9.27MShares$11.7 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$5.63 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.38MShares$3 Million0.01% of portfolio
-
Aqr Capital Management LLC Greenwich, CT2.31MShares$2.91 Million0.0% of portfolio
-
Russell Investments Group, Ltd.2.2MShares$2.77 Million0.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $60.7M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...